| Product Code: ETC9959344 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Antiparasitic Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Antiparasitic Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Antiparasitic Market - Industry Life Cycle |
3.4 United States (US) Antiparasitic Market - Porter's Five Forces |
3.5 United States (US) Antiparasitic Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 United States (US) Antiparasitic Market Revenues & Volume Share, By Disease Indication, 2021 & 2031F |
3.7 United States (US) Antiparasitic Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 United States (US) Antiparasitic Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing pet ownership in the United States leading to higher demand for antiparasitic products |
4.2.2 Rising awareness about the importance of pet healthcare and preventive measures against parasites |
4.2.3 Growth in disposable income allowing pet owners to spend more on antiparasitic treatments |
4.3 Market Restraints |
4.3.1 Stringent regulations and approvals for antiparasitic products leading to longer time-to-market |
4.3.2 Increasing competition among market players resulting in pricing pressures |
4.3.3 Potential side effects and resistance development in parasites towards existing antiparasitic treatments |
5 United States (US) Antiparasitic Market Trends |
6 United States (US) Antiparasitic Market, By Types |
6.1 United States (US) Antiparasitic Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Antiparasitic Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 United States (US) Antiparasitic Market Revenues & Volume, By Anthelmintics, 2021- 2031F |
6.1.4 United States (US) Antiparasitic Market Revenues & Volume, By Antiprotozoals, 2021- 2031F |
6.1.5 United States (US) Antiparasitic Market Revenues & Volume, By Others, 2021- 2031F |
6.2 United States (US) Antiparasitic Market, By Disease Indication |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Antiparasitic Market Revenues & Volume, By Giardiasis, 2021- 2031F |
6.2.3 United States (US) Antiparasitic Market Revenues & Volume, By Trichuriasis, 2021- 2031F |
6.2.4 United States (US) Antiparasitic Market Revenues & Volume, By Filariasis, 2021- 2031F |
6.2.5 United States (US) Antiparasitic Market Revenues & Volume, By Neurocysticercosis, 2021- 2031F |
6.2.6 United States (US) Antiparasitic Market Revenues & Volume, By Hydatid disease, 2021- 2031F |
6.2.7 United States (US) Antiparasitic Market Revenues & Volume, By Others, 2021- 2031F |
6.3 United States (US) Antiparasitic Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 United States (US) Antiparasitic Market Revenues & Volume, By Hospital pharmacies, 2021- 2031F |
6.3.3 United States (US) Antiparasitic Market Revenues & Volume, By Retail pharmacies, 2021- 2031F |
6.3.4 United States (US) Antiparasitic Market Revenues & Volume, By Online pharmacies, 2021- 2031F |
6.3.5 United States (US) Antiparasitic Market Revenues & Volume, By Others, 2021- 2031F |
7 United States (US) Antiparasitic Market Import-Export Trade Statistics |
7.1 United States (US) Antiparasitic Market Export to Major Countries |
7.2 United States (US) Antiparasitic Market Imports from Major Countries |
8 United States (US) Antiparasitic Market Key Performance Indicators |
8.1 Number of veterinary prescriptions for antiparasitic products |
8.2 Adoption rate of novel antiparasitic treatments in the market |
8.3 Frequency of pet wellness visits for parasite prevention and control. |
9 United States (US) Antiparasitic Market - Opportunity Assessment |
9.1 United States (US) Antiparasitic Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 United States (US) Antiparasitic Market Opportunity Assessment, By Disease Indication, 2021 & 2031F |
9.3 United States (US) Antiparasitic Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 United States (US) Antiparasitic Market - Competitive Landscape |
10.1 United States (US) Antiparasitic Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Antiparasitic Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here